Boost Your Health with Coffee: New Study Reveals Surprising Benefits!
reduce heart and Metabolic Diseases coffee
How Drinking Coffee Can Lower the Risk of Heart and Metabolic Diseases
Moderate consumption of coffee or caffeine has been associated with a decreased likelihood of developing multiple cardiometabolic diseases, as evidenced by research utilizing data from the UK Biobank. Specifically, individuals who consumed three cups of coffee or 200-300 mg of caffeine daily exhibited a lower risk of cardiometabolic multimorbidity.
Research Findings
A recent publication in the Journal of Clinical Endocrinology & Metabolism by the Endocrine Society posits that regular intake of moderate quantities of coffee and caffeine may provide a safeguard against the onset of several cardiometabolic conditions, including type 2 diabetes, coronary heart disease, and stroke.
The study reveals that habitual coffee or caffeine consumption, particularly at moderate levels, correlates with a diminished risk of newly diagnosed cardiometabolic multimorbidity (CM), defined as the simultaneous occurrence of at least two cardiometabolic diseases.
Public Health Challenge
The escalating prevalence of individuals suffering from multiple cardiometabolic diseases is emerging as a significant public health challenge, especially in aging populations globally, as highlighted by the study.
Findings suggest that coffee and caffeine consumption may serve a vital protective function throughout various stages of CM development.
reduce heart and Metabolic Diseases coffee: Expert Insights
According to lead researcher Chaofu Ke, M.D., Ph.D., from the Department of Epidemiology and Biostatistics at Suzhou Medical College, “Drinking three cups of coffee, or 200-300 mg of caffeine, daily might lower the risk of developing cardiometabolic multimorbidity among those who are free of any cardiometabolic ailments.”
The investigation indicated that compared to non-consumers or those consuming less than 100 mg of caffeine per day, moderate coffee (three cups daily) or caffeine (200-300 mg per day) drinkers experienced a 48.1% or 40.7% reduction in the risk of new-onset CM.
Methodology: reduce heart and Metabolic Diseases coffee
Utilizing the UK Biobank—a comprehensive longitudinal dietary study encompassing over 500,000 participants aged 37-73 years—the researchers excluded individuals with unclear data regarding caffeine intake.
Ultimately, the analysis included 172,315 participants free of any cardiometabolic diseases at the outset, alongside 188,091 individuals assessed for coffee and tea consumption.
Cardiometabolic disease outcomes were determined through self-reported medical histories, primary care records, linked inpatient hospital data, and death registries associated with the UK Biobank.
Across all consumption levels, coffee and caffeine intake exhibited an inverse correlation with the risk of new-onset CM among participants without existing cardiometabolic diseases, with those reporting moderate intake having the most favorable outcomes. Moderate coffee or caffeine intake was inversely associated with nearly all developmental phases of CM.
“The findings underscore the potential for promoting moderate coffee or caffeine intake as a beneficial dietary practice for the prevention of CM among healthy individuals,” stated Ke.
Addressing Research Gaps
Numerous epidemiological studies have established the protective influence of coffee, tea, and caffeine on single cardiometabolic disease morbidity. However, the effects of these beverages on the emergence of CM have remained largely unexplored.
The authors evaluated existing literature on this subject and discovered that individuals with a single cardiometabolic disease face double the risk of all-cause mortality compared to those free from such conditions.
Conversely, the research indicated that individuals with CM might encounter a mortality risk elevated by nearly four to seven times. The study also pointed out that CM is associated with heightened risks of physical dysfunction and mental distress compared to those with isolated diseases.
Reference
“Habitual Coffee, Tea, and Caffeine Consumption, Circulating Metabolites, and the Risk of Cardiometabolic Multimorbidity” by Xujia Lu et al., September 17, 2024, The Journal of Clinical Endocrinology & Metabolism. DOI: 10.1210/clinem/dgae552
Additional contributors to the study include Xujia Lu, Guochen Li, Luying Wu, Liping Shao, Yulong Fan, and Chen-Wei Pan from Soochow University; Xiaohong Zhu from Suzhou Centers for Disease Control and Prevention, Suzhou, China; Ying Wu from Southern Medical University, Guangzhou, China; and Yan Borné from Lund University, Malmö, Sweden.
This study was funded by the National Natural Science Foundation of China, the Project of MOE Key Laboratory of Geriatric Diseases and Immunology, and the Research on Key Technologies for the Prevention and Control of Major Diseases and Infectious Diseases in Suzhou.
